Skip to main content
NCBI home page
British Medical Journal logoLink to British Medical Journal
. 1974 Jul 13;3(5923):89–92. doi: 10.1136/bmj.3.5923.89

Thyroid Function in Patients Treated with Radioactive Iodine for Thyrotoxicosis

W M G Tunbridge, P Harsoulis, A W G Goolden
PMCID: PMC1611032  PMID: 4855207

Abstract

A series of 105 patients treated at least two years earlier with radioactive iodine for thyrotoxicosis have been surveyed. Eighty-five patients (81%) were euthyroid clinically and on the basis of routine thyroid function tests. Of the euthyroid patients 46 (54%) had normal thyroid-stimulating hormone (TSH) levels and 39 (46%) had raised TSH levels. There was no difference in serum triiodothyronine levels between these two groups but the serum protein bound iodine and serum thyroxine, though still well within the normal range, were significantly lower in the group with raised TSH levels. The serum cholesterol was also significantly higher in this latter group.

Most of the euthyroid patients were seen again a year later. None had become hypothyroid and neither those with normal nor those with raised TSH levels showed any evidence of a decline in the level of serum thyroxine.

It is concluded that raised serum TSH levels in patients treated with iodine-131 are not necessarily indicative of hypothyroidism. There is no indication that patients who have this abnormality become overtly hypothyroid over a 12-month follow up.

Full text

PDF
89

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ADAMS D. D., KENNEDY T. H. EVIDENCE OF A NORMALLY FUNCTIONING PITUITARY TSH SECRETION MECHANISM IN A PATIENT WITH A HIGH BLOOD LEVEL OF LONG-ACTING THYROID STIMULATOR. J Clin Endocrinol Metab. 1965 May;25:571–576. doi: 10.1210/jcem-25-5-571. [DOI] [PubMed] [Google Scholar]
  2. Bellabarba D., Bénard B., Langlois M. Pattern of serum thyroxine, triiodothyronine and thyrotrophin after treatment of thyrotoxicosis. Clin Endocrinol (Oxf) 1972 Oct;1(4):345–353. doi: 10.1111/j.1365-2265.1972.tb00404.x. [DOI] [PubMed] [Google Scholar]
  3. Corcoran J. M., Eastman C. J., Ekins R. P., Paul W. The production of antisera for the radioimmunoassay of thyroxine. J Endocrinol. 1973 Jul;58(1):xxii–xxii. [PubMed] [Google Scholar]
  4. Gimlette T. M. Use of Sephadex column chromatography in the assessment of thyroid status. J Clin Pathol. 1967 Mar;20(2):170–174. doi: 10.1136/jcp.20.2.170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hall R., Amos J., Ormston B. J. Radioimmunoassay of human serum thyrotrophin. Br Med J. 1971 Mar 13;1(5749):582–585. doi: 10.1136/bmj.1.5749.582. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hall R. The immunoassay of thyroid-stimulating hormone and its clinical applications. Clin Endocrinol (Oxf) 1972 Jan;1(1):115–125. doi: 10.1111/j.1365-2265.1972.tb00383.x. [DOI] [PubMed] [Google Scholar]
  7. Hedley A. J., Amos J., Hall R., Michie W., Crooks J. Serum-thyrotropin levels after subtotal thyroidectomy for Graves' disease. Lancet. 1971 Mar 6;1(7697):455–458. doi: 10.1016/s0140-6736(71)91084-1. [DOI] [PubMed] [Google Scholar]
  8. Odell W. D., Wilber J. F., Utiger R. D. Studies of thyrotropin physiology by means of radioimmunoassay. Recent Prog Horm Res. 1967;23:47–85. doi: 10.1016/b978-1-4831-9826-2.50005-2. [DOI] [PubMed] [Google Scholar]
  9. Ormston B. J., Cryer R. J., Garry R., Besser G. M., Hall R. Thyrotrophin-releasing hormone as a thyroid-function test. Lancet. 1971 Jul 3;2(7714):10–14. doi: 10.1016/s0140-6736(71)90005-5. [DOI] [PubMed] [Google Scholar]
  10. PINCHERA A., PINCHERA M. G., STANBURY J. B. THYROTROPIN AND LONG-ACTING THYROID STIMULATOR ASSAYS IN THYROID DISEASE. J Clin Endocrinol Metab. 1965 Feb;25:189–208. doi: 10.1210/jcem-25-2-189. [DOI] [PubMed] [Google Scholar]
  11. Slingerland D. W., Hershman J. M., Dell E. S., Burrows B. A. Thyrotropin and PBI in radioiodine treated hyperthyroid patients. J Clin Endocrinol Metab. 1972 Dec;35(6):912–917. doi: 10.1210/jcem-35-6-912. [DOI] [PubMed] [Google Scholar]
  12. Sterling K., Bellabarba D., Newman E. S., Brenner M. A. Determination of triiodothyronine concentration in human serum. J Clin Invest. 1969 Jun;48(6):1150–1158. doi: 10.1172/JCI106072. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Sterling K., Brenner M. A., Newman E. S., Odell W. D., Bellabarba D. The significance of triiodothyronine (T3) in maintenance of euthyroid status after treatment of hyperthyroidism. J Clin Endocrinol Metab. 1971 Nov;33(5):729–731. doi: 10.1210/jcem-33-5-729. [DOI] [PubMed] [Google Scholar]
  14. Toft A. D., Hunter W. M., Barnes E. W., Seth J., Irvine W. J. Raised plasma-thyroid-stimulating-hormone levels in thyrotoxic patients treated with iodine-131. Lancet. 1973 Sep 22;2(7830):644–645. doi: 10.1016/s0140-6736(73)92481-1. [DOI] [PubMed] [Google Scholar]
  15. Tunbridge W. M., Jackson R. A., Iniguez M., Fraser T. R. Use of thyrotrophin releasing hormone test in pituitary disease. Proc R Soc Med. 1973 Feb;66(2):187–187. doi: 10.1177/003591577306600239. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES